Raltegravir as Early Therapy in African-Americans Living With HIV Study
NCT00667433
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
38
Enrollment
OTHER
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Raltegravir + Truvada
Sponsor
David A Wohl, MD
Collaborators
[object Object]